Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats
- Response deadline
- Oct 16, 2026 Due in 59 days
- Date posted
- Aug 17, 2026
- Source
- Open notice
Description
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $500,000 for Year 1, subject to the availability of funds.This NOFO provides operational support through financial and technical resources to the Ghana Health Service (GHS)/Ministry of Health (MoH). The goal is to help them coordinate and improve laboratory capacity so they can deliver high-quality, efficient services for HIV, TB, and other priority health areas. This NOFO will advance HIV testing, treatment, retention, and viral suppression in Ghana by:Equipping laboratories with appropriate diagnostic technologies.Building staff skills to manage quality laboratory services.Strengthening the capacity of the Government of Ghana (GoG) MoH to take full responsibility for managing laboratory services, diagnostic networks, and systems for HIV, TB, and other priority infectious diseases.
Classifications
- NAICS93.067
Documents (1)
- cdc-rfa-jg-26-0178_v3_for posting.pdfapplication/pdf1.2 MBNot yet available
Contacts
- dghtnofos@cdc.gov404-353-0319
Similar contracts
- Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in IndiaDue Sep 16, 2026
- Improving regional capacity to respond to HIV, TB, and other global health priorities in Central AmericaDue Aug 31, 2026
- Enhancing sustainable health information and laboratory systems and networks for quality detection, management, and monitoring to end HIV and TB as public health threats in IndiaDue Jul 24, 2026
- Sustaining life-saving HIV services in Ukraine by strengthening resilient health systems under the Ukraine Ministry of Health, Public Health CenterDue Jul 20, 2026
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027